schizophrenia
Researchers found that discovering progression to schizophrenia via machine learning based on routine clinical data is 'feasible.'
The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.
The companies will be collaborating on a prescription digital therapeutic for patients with schizophrenia built on Click Therapeutics' tech platform.
The new tool will be released for limited distribution and will provide multimodal neurobehavioral interventions.
Pear Therapeutics has inked a deal with pharma company Novartis to work together on the development of two digital therapeutics for multiple sclerosis and schizophrenia.
A small study recently published in Translational Psychiatry showed that people living with schizophrenia could use a video game paired with an MRI scanner to curb verbal hallucinations.